NCT02567435 2026-03-17
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Tufts Medical Center
GOG Foundation
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Children's Oncology Group